Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AVID BIOSERVICES, INC.

(CDMO)
  Report
Real-time Estimate Cboe BZX  -  01:07 2022-12-05 pm EST
15.67 USD   -4.54%
11/29Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022
AQ
11/16Avid Bioservices Appoints Oksana Lukash as Vice President, People
AQ
11/02Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2022 11/30/2022 12/01/2022 12/02/2022 12/05/2022 Date
14.72(c) 15.66(c) 15.78(c) 16.41(c) 15.74 Last
879 025 703 638 569 505 439 947 112 504 Volume
-1.80% +6.39% +0.77% +3.99% -4.08% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 144 M - -
Net income 2023 4,49 M - -
Net Debt 2023 - - -
P/E ratio 2023 234x
Yield 2023 -
Sales 2024 182 M - -
Net income 2024 15,9 M - -
Net Debt 2024 - - -
P/E ratio 2024 69,1x
Yield 2024 -
Capitalization 1 020 M 1 020 M -
Capi. / Sales 2023 7,09x
Capi. / Sales 2024 5,59x
Nbr of Employees -
Free-Float 98,5%
More Financials
Company
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing, focused on biopharmaceutical drug substances derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing... 
Sector
Pharmaceuticals
Calendar
12/06Earnings Release
More about the company
Ratings of Avid Bioservices, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about AVID BIOSERVICES, INC.
11/29Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 Aft..
AQ
11/16Avid Bioservices Appoints Oksana Lukash as Vice President, People
AQ
11/02Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference
AQ
10/21Avid Bioservices, Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, ..
AQ
10/10TOMI to Install Custom Engineered Integrated iHP System in Avid Bioservices, Inc. Viral..
AQ
10/03Transcript : Avid Bioservices, Inc. Presents at RBC 2022 Virtual Pharmaceutic..
CI
09/27Avid Bioservices to Participate in RBC Global CDMO Conference
AQ
09/22Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
AQ
09/22Avid Bioservices Promotes Michael Alston, Jr. as Vice President, Operations from Role a..
CI
09/14Transcript : Avid Bioservices, Inc. Presents at Morgan Stanley 20th Annual Gl..
CI
09/07Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Confere..
AQ
09/06AVID BIOSERVICES, INC. Management's Discussion and Analysis of Financial Condition And..
AQ
09/06Avid Biosciences Fiscal Q1 EPS Decline; Revenue Rises; Company Reiterates FY Revenue Gu..
MT
09/06Transcript : Avid Bioservices, Inc., Q1 2023 Earnings Call, Sep 06, 2022
CI
09/06Avid Bioservices, Inc. : Results of Operations and Financial Condition, Regulation FD Disc..
AQ
More news
News in other languages on AVID BIOSERVICES, INC.
09/22Avid Bioservices promeut Michael Alston, Jr. au poste de vice-président des opérations ..
09/06Baisse du BPA d'Avid Biosciences au 1er trimestre fiscal ; hausse du chiffre d'affaires..
09/06Avid Bioservices, Inc. annonce ses résultats pour le premier trimestre clos le 31 juill..
09/06Avid Bioservices, Inc. Fournit des prévisions de revenus pour l'exercice 2023
09/06Historique des réactions aux bénéfices : Avid Biose..
More news
Analyst Recommendations on AVID BIOSERVICES, INC.
More recommendations
ETFs positioned on AVID BIOSERVICES, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Invesco S&P SmallCap 600 Pure Growth ETF - USD1.31%1.14%United_States
Invesco S&P SmallCap Health Care ETF - USD1.13%3.26%United_States
ETFs S&P Biotech ETF - Distributing - AUD0.52%1.22%-United_States
SPDR S&P Biotech ETF - USD0.52%5.67%United_States
Vanguard S&P Small-Cap 600 Growth ETF - USD0.3%1.43%United_States
More ETFs positioned on AVID BIOSERVICES, INC.
Chart AVID BIOSERVICES, INC.
Duration : Period :
Avid Bioservices, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVID BIOSERVICES, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 16,41 $
Average target price 26,00 $
Spread / Average Target 58,4%
EPS Revisions
Managers and Directors
Nicholas S. Green President, Chief Executive Officer & Director
Daniel Ryan Hart Chief Financial Officer
Joseph Carleone Director
Nick Ferguson Executive Director-Information Technology
Richard A. Richieri Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
AVID BIOSERVICES, INC.-43.76%1 020
CSL LIMITED3.84%98 736
SAMSUNG BIOLOGICS CO.,LTD.-3.65%47 474
BIOGEN INC.24.58%43 042
WUXI BIOLOGICS (CAYMAN) INC.-44.03%28 080
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-28.50%20 307